Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1975-12-23
|
| pubmed:language |
ita
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0026-4873
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
21
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
324-33
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:4467053-Adult,
pubmed-meshheading:4467053-Dipyridamole,
pubmed-meshheading:4467053-Female,
pubmed-meshheading:4467053-Heart Rate,
pubmed-meshheading:4467053-Heparin,
pubmed-meshheading:4467053-Humans,
pubmed-meshheading:4467053-Hypertension, Malignant,
pubmed-meshheading:4467053-Sympatholytics
|
| pubmed:articleTitle |
[Medical treatment of malignant hypertension. Physiopathological basis and results of treatment with sympatholytic drugs, heparin and dipyridamole].
|
| pubmed:publicationType |
Journal Article
|